Asymptomatic high Epstein-Barr viral load carriage in pediatric renal transplant recipients

Pediatric Transplantation

Volumn 15, Issue 3, 2011, Pages 306-313

  Tanaka, Eriko ^a,b   Sato, Tetsuya ^c   Ishihara, Masayuki ^c   Tsutsumi, Yasushi ^d   Hisano, Masataka ^a   Chikamoto, Hiroko ^a   Akioka, Yuko ^a   Dohno, Sumitaka ^c   Maeda, Akihiko ^c   Hattori, Motoshi ^a   Wakiguchi, Hiroshi ^c   Fujieda, Mikiya ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KOCHI UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Epstein Barr virus; PCR; post transplant lymphoproliferative; renal transplant; T lymphocytes

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; VIRUS DNA;

ADOLESCENT; ARTICLE; BLOOD; CHILD; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; VIRUS LOAD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TREATMENT OUTCOME; VIRAL LOAD;

EID: 79954506693     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01465.x     Document Type: Article

References (19)

1. Holmes RD, Sokol RJ,. Epstein-Barr virus and post-transplant lymphoproliferative disease. Pediatr Transplant 2002: 6: 456-464. (Pubitemid 35470542)
2. Maeda A, Wakiguchi H, Yokoyama W, Hisakawa H, Tomoda T, Kurashige T,. Persistently high Epstein-Barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection. J Infect Dis 1999: 179: 1012-1015. (Pubitemid 29159350)
3. D'Antiga L, Del Rizzo M, Mengoli C, Cillo U, Guariso G, Zancan L,. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insight into the occurrence of late PTLD. Liver Transpl 2007: 13: 343-348. (Pubitemid 46444462)
4. Bingler MA, Feingold B, Miller SA, et al., Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children. Am J Transplant 2008: 8: 442-445.
5. Green M, Soltys K, Rowe DT, Webber SA, Mazareigos G,. Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipients. Pediatr Transplant 2009: 13: 319-323.
6. Nasimuzzaman M, Kuroda M, Dohno S, et al., Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1. Mol Ther 2005: 11: 578-590. (Pubitemid 40353115)
7. Prichett R, Pedersen M, Kieff E,. Complexity of EBV homologous DNA in continuous lymphoblastoid cell lines. Virology 1976: 74: 227-231.
8. Sato T, Fujieda M, Maeda A, et al., Monitoring of Epstein-Barr virus load and killer T cells in pediatric renal transplant recipients. Clin Nephrol 2008: 70: 393-403.
9. Hida N, Maeda Y, Katagiri K, Takasu H, Harada M, Itoh K,. A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation. Cancer Immunol Immunother 2002: 51: 219-228. (Pubitemid 34493956)
10. Gotoh K, Ito Y, Ohta R, et al., Immunologic and virologic analyses in pediatric liver recipients with chronic high Epstein-Barr virus loads. J Infect Dis 2010: 202: 461-469.
11. Axelrod DA, Holmes R, Thomas SE, Magee JC,. Limitations of EBV-PCR monitoring to detect EBV associated post-transplant lymphoproliferative disorder. Pediatr Transplant 2003: 7: 223-227. (Pubitemid 36682147)
12. Green M, Webber S,. EBV viral load monitoring: Unanswered questions. Am J Transplant 2002: 2: 894-895. (Pubitemid 36330216)
13. Suzuki T, Ikezumi Y, Okubo S, et al., Epstein-Barr virus DNA load and seroconversion in pediatric renal transplantation with tacrolimus immunosuppression. Pediatr Transplant 2007: 11: 749-754. (Pubitemid 47512317)
14. Tsai DE, Douglas L, Andreadis C, et al., EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: Results of a two-arm prospective trial. Am J Transplant 2008: 8: 101-1024.
15. Lee TC, Savoldo B, Rooney CM, et al., Quantitative EBV viral loads and immunosuppression alteration can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant 2005: 5: 2222-2228. (Pubitemid 41648469)
16. McDonald RA, Smith JM, Ho M, et al., Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant 2008: 8: 984-989. (Pubitemid 351537758)
17. Smets F, Latinne D, Bazin H, et al., Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 2002: 73: 1603-1610. (Pubitemid 34568673)
18. Lee TC, Goss JA, Rooney CM, et al., Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high -risk for EBV infection. Clin Transpl 2006: 20: 689-694. (Pubitemid 44712268)
19. Maccedo C, Zeevi A, Bentlejewski C, et al., The impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients. Clin Transplant Res 2009: 88: 123-128.